SHAREHOLDERS' EQUITY (Details 2) (USD $)	12 Months Ended														12 Months Ended								12 Months Ended					12 Months Ended
	Jun. 30, 2012 Y	Jun. 30, 2011 Y	Jun. 30, 2010 Y	Jun. 30, 2012 RSAs and RSUs	Jun. 30, 2011 RSAs and RSUs	Jun. 30, 2010 RSAs and RSUs	Jun. 30, 2012 RSAs Y	Jun. 30, 2011 RSAs	Jun. 30, 2010 RSAs	Jun. 30, 2012 RSAs vesting over five anniversaries item	Jun. 30, 2012 RSAs vesting after two years	Jun. 30, 2012 RSUs Y	Jun. 30, 2012 RSUs Less than Y	Jun. 30, 2012 Vested RSUs with deferral of payment until January 31, 2013	Jun. 30, 2012 SARs Y	Jun. 30, 2011 SARs	Jun. 30, 2010 SARs	Jun. 30, 2012 2004 Plan	Jun. 30, 2011 2004 Plan	Oct. 28, 2010 2004 Plan	Jun. 30, 2010 2004 Plan	May 31, 2004 2004 Plan	Jun. 30, 2012 2004 Plan RSAs	Jun. 30, 2012 2004 Plan RSUs	Jun. 30, 2012 2004 Plan Stock options and SARs	Jun. 30, 2012 2000 Plan	Jun. 30, 2010 2000 Plan	Jun. 30, 2012 2000 Plan Incentive stock options, greater than 10 percent voting power	Jun. 30, 2012 2000 Plan Director options
Stock-based compensation award plans
Common stock authorized for issuance (in shares)																				6,750,000		2,500,000
Percentage of stock-based awards vesting annually on each of the first five anniversaries of the date of grant																							20.00%		20.00%
Vesting period											2 years	2 years											5 years	5 years	5 years
Number of anniversaries										5
Maximum term of awards																									P10Y	P10Y		P5Y	P10Y
Shares available for grant	4,838,000	4,209,000	16,000															4,838,000	4,209,000		12,000						4,000
Shares previously available for grant																										3,500,000
Percentage of voting power in excess of which tenure of award would not exceed five years																												10.00%
Stock options outstanding
Balance at the beginning of the period (in shares)	838,000	980,000	1,385,000
Granted (in shares)			135,000
Cancelled (in shares)	(186,000)	(96,000)	(337,000)
Exercised (in shares)		(45,933)	(202,700)
Balance at the end of the period (in shares)	652,000	838,000	980,000
Exercisable at the end of the period (in shares)	593,000
Stock options, weighted average exercise price
Balance at the beginning of the period (in dollars per share)	$ 31.48	$ 29.48	$ 25.55
Granted (in dollars per share)			$ 18.90
Cancelled (in dollars per share)	$ 27.80	$ 18.89	$ 17.74
Exercised (in dollars per share)		$ 15.04	$ 15.12
Balance at the end of the period (in dollars per share)	$ 32.53	$ 31.48	$ 29.48
Exercisable at the end of the period (in dollars per share)	$ 33.50
Intrinsic value of exercisable options (in dollars)	$ 0
Outstanding options, weighted average remaining contractual term (in years)	3.4
Weighted average remaining contractual term of exercisable options (in years)	3.0
Options expected to vest (in shares)	54,458
Options expected to vest, weighted average exercise price (in dollars per share)	$ 22.82
Options expected to vest, weighted average remaining contractual life (in years)	6.5
Options expected to vest, total intrinsic value (in dollars)	0
Rollforward of RSAs, RSUs and SARs outstanding
Nonvested at the beginning of the period (in shares)	1,077,000	1,146,000		1,077,000	1,146,000	1,032,000
Outstanding at the beginning of the period (in shares)															1,087,000	1,110,000	1,114,000
Granted (in shares)				97,000	277,000	304,000	55,000			20,000	35,000	42,316				103,000	2,000
Forfeited or expired (in shares)				(290,000)	(118,000)	(2,000)									(352,000)	(126,000)	(6,000)
Vested/Exercised (in shares)				(224,000)	(228,000)	(188,000)						(25,704)			(1,000)
Outstanding at the end of the period (in shares)							403,120					257,316			734,000	1,087,000	1,110,000
Nonvested at the end of the period (in shares)	420,000	1,077,000	1,146,000	660,000	1,077,000	1,146,000						16,612
RSAs, RSUs and SARs outstanding, other relevant terms of the awards
Outstanding and unvested awards (in shares)	420,000	1,077,000	1,146,000	660,000	1,077,000	1,146,000						16,612
Weighted Average Grant Date Fair Value, nonvested at the beginning of the period (in dollars per share)				$ 23.48	$ 24.70	$ 26.33
Weighted Average Grant Date Fair Value, Granted (in dollars per share)				$ 16.94	$ 16.60	$ 19.12	$ 16.15	$ 16.60	$ 19.12			$ 17.96				$ 6.26	$ 8.60
Weighted Average Grant Date Fair Value, Forfeited or Expired (in dollars per share)				$ 19.07	$ 20.42	$ 20.02
Weighted Average Grant Date Fair Value, Vested/Exercised (in dollars per share)				$ 20.58	$ 22.69	$ 24.74
Weighted Average Grant Date Fair Value, nonvested at the end of the period (in dollars per share)				$ 25.44	$ 23.48	$ 24.70
Vesting rate (as a percent)										20.00%
Weighted Average Exercise Price, outstanding at the beginning of the period (in dollars per share)															$ 25.54	$ 26.24	$ 26.30
Weighted Average Exercise Price, Granted (in dollars per share)																$ 16.60	$ 28.57
Weighted Average Exercise Price, Forfeited or Expired (in dollars per share)															$ 24.57	$ 24.35	$ 38.63
Weighted Average Exercise Price, Vested or Exercised (in dollars per share)															$ 16.60
Weighted Average Exercise Price, outstanding at the end of the period (in dollars per share)															$ 26.02	$ 25.54	$ 26.24
Exercisable at the end of the period (in shares)															579,790
Exercisable awards, intrinsic value															100,000
Outstanding and unvested awards, intrinsic value							7,200,000
Outstanding awards, intrinsic value												4,600,000			100,000
Outstanding and unvested awards (in shares)							366,864
Outstanding awards, weighted average remaining contractual term (in years)							1.7					0.1	0.1		3.8
Vested awards (in shares)												240,704		215,000
Vested awards, intrinsic value												4,300,000
Unvested awards (in shares)	420,000	1,077,000	1,146,000	660,000	1,077,000	1,146,000						16,612
Unvested awards, weighted average remaining contractual term (in years)												0.5
Total fair value of stock awards vested	4,800,000	5,400,000	4,900,000
Period for which payment is deferred												6 months
Outstanding and unvested awards expected to vest, total intrinsic value (in dollars)							6,600,000								1,000,000
Outstanding and unvested awards expected to vest, weighted average grant price (in dollars per share)															$ 18.99
Outstanding and unvested awards expected to vest, weighted average remaining contractual term (in years)															6.9
Unvested RSAs with accelerated vesting period held by the company's chief executive officer and the company's executive vice president (in shares)							68,390
Incremental compensation cost recognized as a result of the modifications							200,000	100,000
Weighted average remaining contractual term of exercisable options (in years)															2.9
Stock-based compensation award plans, additional disclosures
Cash received from exercise of share-based instruments	100,000	700,000	3,100,000
Unrecognized compensation cost related to unvested stock-based compensation	7,800,000
Weighted average period of recognition of unrecognized compensation cost related to unvested stock-based compensation (in years)	2.6
Intrinsic value of share-based awards exercised	100,000	200,000	700,000
Stock options, weighted average grant date fair value (in dollars per share)			$ 7.36
Compensation expense	7,600,000	9,600,000	9,300,000
Outstanding options, intrinsic value (in dollars)	$ 0
Assumptions used in determining fair value of stock options and SARs
Risk-free interest rate (as a percent)		2.29%	2.79%
Expected term (in years)		5.50	5.50
Expected volatility (as a percent)		44.00%	42.00%
Expected dividend yield (as a percent)		1.45%	0.85%